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Cerebral venous and sinus thrombosis in adult patient – Case report 
 
Tromboza vena i venskih sinusa mozga – Prikaz slučaja 
 




Cerebral venous and sinus thrombosis (CVST) is a rare type of cerebrovascular disease which accounts 
for <1% of all strokes. It can occur at any age and is characterized by thrombus within the cerebral venous 
and sinus system. The paper reviews the case of a 73-year-old woman hospitalized after the onset of severe 
headache, dizziness, nausea, vomiting and right-sided hemiparesis 4/5 degree. The suggestive signs of cerebral 
venous and sinus thrombosis (CVST) were hyperdense signal and empty delta sign on computed tomography 
(CT) image and the combination of the absence of a flow void with alternation of signal intensity in the dural 
sinus on magnetic resonance imaging (MRI). Except for the elevated D-dimer values, other laboratory findings 
were within reference range. Genetic disorders, acquired coagulation disorders and malignancies were 
excluded. The patient was treated with body weight-adjusted subcutaneous low-molecular-weight heparin 
(LMWH) with a good clinal response – dissapearance of signs and symptoms and the absence of 
complications. She took oral anticoagulant therapy after the acute phase of the disease. 





Tromboza moždanih vena i venskih sinusa rijedak je oblik cerebrovaskularne bolesti koja čini <1% svih 
moždanih udara, a može se pojaviti u bilo kojoj dobi. Karakterizirana je stvaranjem tromba unutar vena i 
duralnih sinusa mozga. U radu je prikazan slučaj 73-godišnje bolesnice hospitalizirane nakon glavobolje jakog 
intenziteta, vrtoglavice, mučnine, povraćanja i kljenuti desnih udova 4/5 stupnja. Hiperdenzitet  i „prazan delta 
znak“ na kompjutoriziranoj tomografiji (CT) mozga, te kombinacija odsutnosti protoka s promjenom 
intenziteta signala u duralnim sinusima na magnetskoj rezonanciji (MR) bili su znaci tromboze moždanih vena 
i sinusa. Osim povišenih vrijednosti D-dimera, ostali laboratorijski nalazi bili su unutar referentnih vrijednosti. 
Dodatnom obradom isključeni su genetski i stečeni poremećaji koagulacije, a rezultati laboratorijske i 
radiološke obrade u svrhu otkrivanja maligne bolesti bili su negativni. Bolesnica je liječena potkožnom 
primjenom niskomolekularnog heparina, nakon čega je došlo do nestanka simptoma i znakova bolesti. Tijek 
bolesti protekao je bez komplikacija. Nakon akutne faze bolesti nastavljena je oralna antikoagulantna terapija. 
Ključne riječi: tromboza vena i venskih sinusa mozga, glavobolja, kompjutorizirana tomografija, 
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Cerebral venous and sinus thrombosis (CVST) is a 
relatively rare cause and atypical form of cerebral stroke 
which accounts for < 1% of all strokes. It is 
characterized by thrombus within the cerebal venous 
and sinus system.1,2 Cerebral venous and sinus 
thrombosis (CVST) can occur at any age, including the 
neonatal period. This type of cerebrovascular disease is 
more frequent in young adults. The incidence is 3-4 
cases per 2 million per year in adult population, and 0.67 
cases per 100 000 children below 18 years.2,3,4 The 
predisposing factors include the use of oral 
contraceptives (OCC), pregnancy, childbirth, congenital 
and aquired coagulation disorders, neoplastic processes, 
cardiac defects, systemic diseases of the connective 
tissue, Behҫet's disease, injuries, surgical procedures, 
inflammatory disease of the head and neck region, 
nephrotic syndrome, diarrhoea, dehidration, shock.2,5,6,7 
Risk factors cannot be identified in about 15% of the 
cases.5,8 CVST are associated with accelerated 
coagulation and increased blood density, and occurs 
following endothelial damage and decelerated blood 
flow occur.2 
Diagnosis is still frequently overlooked or delayed 
due to the wide spectrum of clinical symptoms and 
presentation. The clinical symptoms of CVST are non-
specific, such as headache, symptoms associated with 
increased intracranial pressure without hydrocephalus, 
focal symptoms, epileptic seizures and consciousness 
disorders.1 Headache is the most frequent symptom and 
occurs in about 90% of all the cases. Increased 
intracranial pressure occurs in almost 20-40% of CVST 
cases, focal and generalised seizures in 40% of the cases 
and focal neurological signs in 40-60% of the cases. 
Stupor or coma is found in 15-19% of patients at 
hospital admission and is usually seen in cases with 
extensive thrombosis.5 
The diagnosis is based on neuroimaging – computed 
tomography (CT), magnetic resonance imaging (MRI), 
computed tomography angiography (CTA), magnetic 
resonance angiography (MRA), digital subtraction 
angiography (DSA), magnetic resonance venography 
(MRV). Computed tomography angiography (CTA) 
and magnetic resonance angiography (MRA) enable the 
characterisation of the blood flow in the pathologically 
affected vessels. Magnetic resonance imaging (MRI) 
provides better visualisation of the lesions than 
computed tomography (CT).9 CTA or MRI is 
recommended for thrombosis detection, and CT can 
detect thrombosis in about 60% of the cases. MRI 
combined with MRA is especially sensitive.9 In 
ambiguous cases, digital subtraction angiography 
(DSA) may be used for diagnosis.9,10 MRI and MRV are 
regarded the best methods for the diagnosis and follow-
up of CVST.3,6,10 MRI in combination with MRV have 
become the noninvasive imagin tehniques of choice and 
are often used as the initial diagnostic methods for 
suspicious cases.10 The T2-weighted -gradient-echo 
MRI and MRV sequence have a high diagnostic value 
for detecting both acute and subacute superior sagitals 
sinus, deep veins, and cortical veins thrombosis.11 
The treatment consists of anticoagulants such as 
dose-adjusted intravenous heparin or body weight-
adjusted subcutaneous low-molecular-weight heparin 
(LMWH), thrombolysis and symptomatic therapy of 
epileptic seizures and increased intracranial pressure.1,12 
The main intervention in the acute CSVT is 
anticoagulation therapy (heparin or LMWH).1 In 
patients in severe condition on admission or in those 
who deteriorate despite adequate anticoagulation 
therapy and in which the other causes of deterioration 
have been ruled out, systemic or local thrombolysis or 
thrombectomy is an option.1,3,6,13 Decompressive 
surgery is the method in patients with large veonus 
infarcts or haemorrhage.1,14 After the acute phase of the 
disease, continued oral anticoagulant therapy (OAT) is 
recommended for a variable period of time, depending 
on the inherent thrombotic risk.1,2,13 About 80% of cases 
have a good prognosis,15 and around 15% of the patients 
remain disabled or die.5 Recurrence of the disease 
affects approximately 15% of patients. The mortality 
rate in the first month after the onset of disease is up to 
13%.16 In a multinational multicentric prospective study 




A 73-year-old woman presented with a severe 
headache which started the night before medical 
examination and with dizziness, nausea and vomiting on 
the day of admission. She had no clinical or neurological 
disturbances at physical examination in the emergency 
room. High blood pressure was registered. During the 
day she developed right-sided hemiparesis 4/5 degree. 
Persistent headache was the dominant symptom. Five 
years earlier she was treated because of transient 
weakness of the left limbs. She had antihypertensive, 
statin, antidepressant and vitamin D in therapy. 
The results of laboratory findings which were made 
in the emergency room were within reference values, 
except for elevated D-dimer. Unenhanced CT scan of 
the head demonstrated a hyperdense signal in the 
superior sagittal sinus (Picture 1), right transverse sinus, 
rectum sinus and in vena magnum Galeni. After 
intravenous contrast was given, the CT demonstrated an 
empty delta sign in the superior sagittal sinus which was 
indicative of CVST (Picture 2).





Picture 1 Unenhanced CT image show hyperdensity within superior sagittal sinus 





Picture 2 Contrast enhanced CT image shows filling defect with enhancing rim (empty delta sign) 
Slika 2. Kontrastom poboljšan CT pokazuje nedostatk punjenja s povećanjem ruba (prazan delta znak) 
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In order to detect the cause of CVST, the patient 
underwent complete laboratory, clinical, ultrasound 
and radiological examination during the hospital stay 
in the Department of Neurology. Except for elevated 
D-dimer, laboratory findings were within reference 
range. Genetic and acquired coagulation disorders 
were excluded, as well as the existence of malignancies. 
CTA registered a filling defect within the superior 
sagittal sinus which corresponded to thrombosis. MRI 
(1.5 T) of the brain without contrast showed hyper-
intensity at superior sagittal sinus, bilateral transverse 
sinus and rectum sinus on T1-weight gradient echo 
sequences, and MRI with contrast showed a visible 
filling defect within the venous sinuses. MRV using 
two- dimensional time-of-flight (2D TOF) technique 
showed a loss of flow in superior sagittal sinus and 
marginally maintained flow in bilateral transverse 
sinus. MRA using three- dimensional time-of-flight 
(3D TOF) technique showed reduced flow in the distal 
part and in M2 branches of the right arteria cerebri 
media (ACM). 
The patient had no contraindications for 
anticoagulation (AC) therapy, so she was treated with 
body weight-adjusted subcutaneous LMWH with a 
good clinal response – disappearance of signs and 
symptoms and the absence of complications. She took 




In our patient, who was earlier treated because of 
hypertension, hypercholesterolemia, depression and 
osteoporosis, laboratory findings and neuroimaging 
methods were made because of sudden headache, 
dizziness, nausea, vomiting and weakness of the right 
limbs. She had elevated serum D-dimer values. Several 
studies have tested the value of D-dimer 
measurements. In most patients with recent CVST, D-
dimer concentrations were elevated, so a negative D-
dimer assay may make the diagnosis of CVST very 
unlikely.17,18,19 In the study Crassard et al., in a series 
of 73 patients with CVST of less than 30 days duration, 
26% of those who presented with isolated headache 
had normal D-dimer concentrations.20 Thus, D-dimer 
concentrations are raised in most patients but normal 
D-dimer levels do not exclude the diagnosis of CVST, 
particularly in patients presented with isolated 
headache.20,21 In our case the CT scan of the head 
showed multiple segmental cerebral sinovenous 
thrombosis. In the study of Wang et. al. two or more 
sinus were affected in 78.9% cases,22 which was also 
found in our patient. Headache was the first and 
dominant symptom in our patient. Headache is the 
most frequent symptom and occurs in about 90% of all 
the cases,5,22 and it is indicative of intracranial 
hypertension resulting from impaired venous drainage 
in patients with CVST.22 Focal neurological signs 
occur in 40-60% of all the cases5 and were registered 
on the second day of the onset of the disease in our 
patient. In patients with headache, focal deficit, 
epileptic seizures or an altered consciousness, CVST 
should always be considered.1,5 In our paper diagnosis 
of CVST was made by using CT scan of the head. 
Unenhanced CT scan is the most frequent examination 
performed in emergencies. In CT imaging without 
contrast, thrombosis is manifested as hyperdensity,9,23 
and CVST may be detected in about 25% of the 
cases.24 High density is a characteristic of the clot for 
the first week, and later it becomes iso- or hypodense.25 
Hyperdense thrombus in a sinus or a vein is a 
radiological sign of CVST,9,23,25 as we found in our 
patient. Thrombosis is detected in about 60% of the 
cases in which contrast enhanced CT was used, and the 
false-negative rate can be as high as 40%.9 Contrast 
enhanced CT reveals better modality for identifying 
dural venous sinus thrombosis and delta sign23,26 which 
we registered in our patient. In patients in which CT of 
the brain without contrast is negative and there is a 
clinical suspicion of CVST, it is necessary to do CT 
with contrast. Empty delta sign on CT image and the 
combination of absence of a flow void with alternation 
of signal intensity in the dural sinus on MRI are the 
suggestive signs of CVST,26 as we found in our patient. 
In MRV of our patient, we registrated a loss of flow in 
superior sagittals sinus and maintained flow in bilateral 
transverse sinus. MRI in combination with MRV are 
the noninvasive imaging methods of choice for 
diagnosis suspicious cases.10 The patient underwent 
extensive diagnostic procedures, but the cause of sinus 
thrombosis was not found and CVST from our paper is 
classified as an idiopathic encountered in about 15% of 
patients.5,8 Despite good recovery after CVST,15 about 
50% of survivors may become depressed or anxious,27 
however, worsening of depression in our patient was 
not registered. Due to the recommended European 
Federation of Neurological Societies (EFNS) 
guidelines on the treatment of cerebral venous and 
sinus thrombosis,1 our patient was treated with body 
weight-adjusted subcutaneous LMWH with the 
disappearance of symptoms and signs and the absence 
of complications. She took OAT after the acute phase 
of the disease. In previous studies CVST had a 
favourable outcome.15 In our patient anticoagulant 
therapy led to complete recovery of neurological signs 
and symptoms. In the study by Ferro and contributors, 
in people aged 65 years and older CVST and isolated 
intracranial hypertension are less frequent than in 
young people. In elderly people decreased levels of 
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consciousness and mental status changes are more 
frequent than in younger people,27 which was not the 
case with our patient. Carcinoma is more frequent as a 
cause of CVST in the elderly and an extensive search 
for cancer should be made to all the patients,25 what we 
have done in our patient. There are insufficient data 
about the duration of OAT in patients with CVST. 
OAT is recommended for more than 6-12 months in 
patients with idiopathic CVST and for those with mild 
thrombophilia.1 In the study Ferro and contributors, 
anticoagulant therapy is recommended for more than 6 





In our report, we presented a case of multiple 
segmental sinovenous thrombosis with good 
prognosis. Early diagnosis and application of 
anticoagulant therapy affect the outcome of CVST. 
The aims of antithrombotic therapy in CVST are to 
recanalise the occluded sinus or vein, to prevent the 
propagation of the thrombus, and to treat the 
underlying protrombotic state in order to prevent 
venous thrombosis in other parts of the body and to 
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